Ajim Tamboli's most recent trade in Monte Rosa Therapeutics Inc was a trade of 129,850 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 3, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Inc | Ajim Tamboli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 129,850 | 129,850 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Ajim Tamboli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 111,700 | 111,700 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Ajim Tamboli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 100,938 | 100,938 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Ajim Tamboli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 56,649 | 56,649 | - | - | Stock Option (Right to Buy) |